Under the contract, CellSource, which operates a cell-processing center (CPC), will evaluate methods to prepare MSC preparations from adipose tissue provided by medical institutions, and how to transport these preparations to Rohto for evaluation in pharmaceutical studies.

CellSource news release, September 8, 2017